Registered South Africa · SAHPRA

CREON 25 000

Pancreatin

28/11.1/0645 INN generic

What it does

Pancreatin is a digestive enzyme that helps the body break down food, especially fats, proteins, and carbohydrates.

Commonly used for: pancreatic insufficiency, malabsorption syndrome, cystic fibrosis

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
28/11.1/0645
Registration date
1996/06/21
Expiry date
-
Status
Registered
Active ingredient
Pancreatin
Dosage form
-
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Country of origin
-

Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:11:17 · updated 2026-09-16 04:00:04

Drug Interactions

1
Check interactions

Unknown (1)

Acarbose - decreases effects

Pancreatinispredictedtodecreasetheeffectsofacarbose. Avoid.oTheoretical

Unknown Theoretical

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: exact

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.

About this medicine

Pancreatin is a digestive enzyme that helps the body break down food, especially fats, proteins, and carbohydrates.

What it treats

  • pancreatic insufficiency
  • malabsorption syndrome
  • cystic fibrosis

How it works

It provides enzymes that the pancreas normally produces, aiding in digestion.

Who it's for

It is for people who have trouble digesting food due to pancreatic issues.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Pancreatin

BNF-referenced

Pancreatin is a pancreatic enzyme supplement used to compensate for reduced or absent exocrine pancreatic secretion, aiding in the digestion of starches, fats, and proteins. It is commonly administered in cases of pancreatic insufficiency, which may arise from conditions such as cystic fibrosis, chronic pancreatitis, or surgical removal of the pancreas.

Indications

  • Exocrine pancreatic insufficiency
  • Cystic fibrosis
  • Chronic pancreatitis
  • Post-surgical states involving the pancreas

Dosage

Children: Children aged 1–11 months: 1–2 capsules mixed with feeds. Children aged 1–17 years: 2–6 capsules to be taken with each meal, either swallowed whole or sprinkled on food.

Adults: Initially 1–2 capsules taken with each meal, and 1 capsule taken with snacks. Capsules may be swallowed whole or the contents mixed with a slightly acidic liquid or soft food, then swallowed immediately without chewing.

Mechanism of action

Pancreatin consists of a mixture of digestive enzymes including amylase, lipase, and proteases. These enzymes work in the gastrointestinal tract to break down carbohydrates, fats, and proteins into smaller molecules that can be easily absorbed by the body. The action of these enzymes is crucial, as their absence due to pancreatic insufficiency leads to malabsorption and nutrient deficiencies.

Pharmacodynamics

The pharmacodynamic effects of pancreatin are primarily seen in the gastrointestinal tract where it enhances digestion and nutrient absorption. By providing the necessary enzymes that are lacking in patients with pancreatic insufficiency, pancreatin helps alleviate symptoms such as steatorrhea (fatty stools), abdominal discomfort, and weight loss. It helps improve the overall nutritional status of patients.

Pharmacokinetics

Pancreatin is administered orally and is inactivated by gastric acid, making it necessary to take it with food or immediately before or after meals for optimal effect. The enzymes are released in the duodenum where they exert their action. The absorption of the resulting products of digestion occurs in the small intestine. The exact pharmacokinetic profile, including half-life and metabolism of the individual enzymes, varies and is often not detailed due to the complex nature of enzyme activity and digestion.

Adverse effects

  • Abdominal distension
  • Constipation
  • Nausea
  • Vomiting
  • Skin reactions
  • Fibrosing colonopathy

Interactions

  • Pancreatin may reduce the effects of acarbose

Precautions

  • Can irritate the perioral skin and buccal mucosa if retained in the mouth
  • Excessive doses can cause perianal irritation

Pregnancy

Not known to be harmful.

Breast-feeding

Not known to be harmful.

Storage

Store in a cool, dry place. Keep the container tightly closed.

Formulations

  • CREON® 10000
  • CREON® 25000
  • CREON® 40000
  • PANCREX® V CAPSULES
  • PANCREX® V POWDER
  • PANCREX® V TABLETS
  • PANCREX® V TABLETS FORTE
  • CREON® MICRO
BNF 85 (British National Formulary) p.92 BNF for Children 2019-2020 p.96 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Pancreatin

PubChem CID 284483

Molecular formula: C13H17NO4S

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.